SQZ Biotech Stock

sqzbiotech.comHealthcareFounded: 2013Funding to Date: $102.44MM

SQZ Biotech is a unique cell therapy company, utilizing a proprietary CellSqueeze® platform to develop a new generation of cell therapies.

Register for Details

For more details on financing and valuation for SQZ Biotech, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for SQZ Biotech.

Register Today

Team

Management Team

Armon Sharei Ph.D
Co-Founder, Board Member, Chief Executive Officer, Co-President and Secretary
Devin Bridgen
Senior Manager and Business Development Executive
Christopher Love Ph.D
Scientific Advisor
Amy Schulman JD
Executive Chairman
Volker Herrmann MD
Board Member, Co-President and Chief Operating Officer
Klavs Jensen Ph.D
Co-Founder and Board Member
Robert Langer Ph.D
Co-Founder and Board Member
Teri Loxam
Chief Financial Officer
Howard Bernstein Ph.D
Chief Scientific Officer
Oliver Rosen MD
Chief Medical Officer

Board Members

Armon Sharei Ph.D
Eric Moessinger
NanoDimension
Jonathan Fleming
20/20 HealthCare Partners
Robert Langer Ph.D
Alexis Ji Ph.D
Illumina Ventures
Garry Nicholson
Klavs Jensen Ph.D
Pushkal Garg
Zafrira Avnur Ph.D
Quark Venture
Amy Schulman JD
Isaac Ciechanover
Mark Murcko Ph.D

Other companies like SQZ Biotech in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Roche, the world’s biggest cancer drug company, selected the technology of startup SQZ Biotechnologies to help it develop new cellular therapies for